Interestingly, post-stroke bacteriotherapy using SCFA-producers and inulin increased SCFA levels in the gut, plasma, and brain, and synergistically improved post-stroke recovery by reducing IL-17 production in γδ T cells in the brains of aged stroke mice. This evidence concerns the gene IL17A and Stroke.